ReP USP - Resultado da busca

Artigo de periodico
In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium (2022)
Hajjar, Braa; Zuo, Jieyu; Park, Chulhun; Azarmi, Shirzad; Silva, Daniela Amaral; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar
Source: AAPS PharmSciTech. Unidade: FCF
Subjects: ANTI-INFLAMATÓRIOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HAJJAR, Braa et al. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium. AAPS PharmSciTech, v. 23, p. 1-9 art. 102, 2022Tradução . . Disponível em: https://doi.org/10.1208/s12249-022-02258-0. Acesso em: 20 maio 2024.
APA
Hajjar, B., Zuo, J., Park, C., Azarmi, S., Silva, D. A., Bou-Chacra, N. A., & Löbenberg, R. (2022). In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium. AAPS PharmSciTech, 23, 1-9 art. 102. doi:10.1208/s12249-022-02258-0
NLM
Hajjar B, Zuo J, Park C, Azarmi S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium [Internet]. AAPS PharmSciTech. 2022 ; 23 1-9 art. 102.[citado 2024 maio 20 ] Available from: https://doi.org/10.1208/s12249-022-02258-0
Vancouver
Hajjar B, Zuo J, Park C, Azarmi S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium [Internet]. AAPS PharmSciTech. 2022 ; 23 1-9 art. 102.[citado 2024 maio 20 ] Available from: https://doi.org/10.1208/s12249-022-02258-0
Artigo de periodico
Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions (2022)
Silva, Daniela Amaral ; Davies, Neal M; Bou-Chacra, Nadia Araci ; Ferraz, Humberto Gomes ; Löbenberg, Raimar
Source: Dissolution Technologies. Unidade: FCF
Subjects: TRATO GASTROINTESTINAL, FARMACOCINÉTICA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, v. 29, n. 2, p. 62-75, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P62. Acesso em: 20 maio 2024.
APA
Silva, D. A., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2022). Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, 29( 2), 62-75. doi:10.14227/DT290222P62
NLM
Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 maio 20 ] Available from: https://doi.org/10.14227/DT290222P62
Vancouver
Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 maio 20 ] Available from: https://doi.org/10.14227/DT290222P62
Trabalho de evento
In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium (2022)
Hajjar, Braa; Zuo, Jieyu ; Azami, Shirzad; Silva, Daniela Amaral ; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar
Source: Abstracts. Conference titles: Research Day Equity in Health and Research. Unidade: FCF
Assunto: FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HAJJAR, Braa et al. In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium. 2022, Anais.. Alberta: University of Alberta, 2022. Disponível em: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf. Acesso em: 20 maio 2024.
APA
Hajjar, B., Zuo, J., Azami, S., Silva, D. A., Bou-Chacra, N. A., & Löbenberg, R. (2022). In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium. In Abstracts. Alberta: University of Alberta. Recuperado de https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf
NLM
Hajjar B, Zuo J, Azami S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium [Internet]. Abstracts. 2022 ;[citado 2024 maio 20 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf
Vancouver
Hajjar B, Zuo J, Azami S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium [Internet]. Abstracts. 2022 ;[citado 2024 maio 20 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf
Artigo de periodico
A BCS-based biowaiver approach using biphasic dissolution test (2021)
Silva, Daniela Amaral; Melo, Katherine Jasmine Curo; Davies, Neal M; Bou-Chacra, Nadia Araci ; Ferraz, Humberto Gomes ; Löbenberg, Raimar
Source: Dissolution Technology. Unidade: FCF
Subjects: BIOEQUIVALÊNCIA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. A BCS-based biowaiver approach using biphasic dissolution test. Dissolution Technology, v. 28, n. 4, p. 40-48, 2021Tradução . . Disponível em: https://doi.org/10.14227/DT280421P40. Acesso em: 20 maio 2024.
APA
Silva, D. A., Melo, K. J. C., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2021). A BCS-based biowaiver approach using biphasic dissolution test. Dissolution Technology, 28( 4), 40-48. doi:10.14227/DT280421P40
NLM
Silva DA, Melo KJC, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. A BCS-based biowaiver approach using biphasic dissolution test [Internet]. Dissolution Technology. 2021 ; 28( 4): 40-48.[citado 2024 maio 20 ] Available from: https://doi.org/10.14227/DT280421P40
Vancouver
Silva DA, Melo KJC, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. A BCS-based biowaiver approach using biphasic dissolution test [Internet]. Dissolution Technology. 2021 ; 28( 4): 40-48.[citado 2024 maio 20 ] Available from: https://doi.org/10.14227/DT280421P40
Artigo de periodico
The lymphatic system: a sometimes-forgotten compartment in pharmaceutical sciences (2021)
Yousef, Malaz ; Silva, Daniela Amaral; Bou-Chacra, Nadia Araci ; Davies, Neal M; Löbenberg, Raimar
Source: Journal of Pharmacy & Pharmaceutical Sciences. Unidade: FCF
Subjects: SISTEMA LINFÁTICO, FISIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOUSEF, Malaz et al. The lymphatic system: a sometimes-forgotten compartment in pharmaceutical sciences. Journal of Pharmacy & Pharmaceutical Sciences, v. 24, p. 533-547, 2021Tradução . . Disponível em: https://doi.org/10.18433/jpps32222. Acesso em: 20 maio 2024.
APA
Yousef, M., Silva, D. A., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2021). The lymphatic system: a sometimes-forgotten compartment in pharmaceutical sciences. Journal of Pharmacy & Pharmaceutical Sciences, 24, 533-547. doi:10.18433/jpps32222
NLM
Yousef M, Silva DA, Bou-Chacra NA, Davies NM, Löbenberg R. The lymphatic system: a sometimes-forgotten compartment in pharmaceutical sciences [Internet]. Journal of Pharmacy & Pharmaceutical Sciences. 2021 ; 24 533-547.[citado 2024 maio 20 ] Available from: https://doi.org/10.18433/jpps32222
Vancouver
Yousef M, Silva DA, Bou-Chacra NA, Davies NM, Löbenberg R. The lymphatic system: a sometimes-forgotten compartment in pharmaceutical sciences [Internet]. Journal of Pharmacy & Pharmaceutical Sciences. 2021 ; 24 533-547.[citado 2024 maio 20 ] Available from: https://doi.org/10.18433/jpps32222
Tese (Doutorado)
Novel biopharmaceutical development investigations towards drug and formulation performance optimization (2021)
Silva, Daniela Amaral ; Bou-Chacra, Nadia Araci (Orientador)
Unidade: FCF
Assunto: MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral. Novel biopharmaceutical development investigations towards drug and formulation performance optimization. 2021. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2021. Disponível em: https://www.teses.usp.br/teses/disponiveis/9/9139/tde-14102022-142944/. Acesso em: 20 maio 2024.
APA
Silva, D. A. (2021). Novel biopharmaceutical development investigations towards drug and formulation performance optimization (Tese (Doutorado). Universidade de São Paulo, São Paulo. Recuperado de https://www.teses.usp.br/teses/disponiveis/9/9139/tde-14102022-142944/
NLM
Silva DA. Novel biopharmaceutical development investigations towards drug and formulation performance optimization [Internet]. 2021 ;[citado 2024 maio 20 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9139/tde-14102022-142944/
Vancouver
Silva DA. Novel biopharmaceutical development investigations towards drug and formulation performance optimization [Internet]. 2021 ;[citado 2024 maio 20 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9139/tde-14102022-142944/
Artigo de periodico
Biphasic dissolution as an exploratory method during early drug product development (2020)
Silva, Daniela Amaral; Gousous, Jozef Al; Davies, Neal M; Bou-Chacra, Nadia Araci ; Webster, Gregory K; Lipka, Elke; Amidon, Gordon L; Löbenberg, Raimar
Source: Pharmaceutics. Unidade: FCF
Subjects: ANTI-INFLAMATÓRIOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. Biphasic dissolution as an exploratory method during early drug product development. Pharmaceutics, v. 12, p. 1-17 art, 2020Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics12050420. Acesso em: 20 maio 2024.
APA
Silva, D. A., Gousous, J. A., Davies, N. M., Bou-Chacra, N. A., Webster, G. K., Lipka, E., et al. (2020). Biphasic dissolution as an exploratory method during early drug product development. Pharmaceutics, 12, 1-17 art. doi:10.3390/pharmaceutics12050420
NLM
Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon GL, Löbenberg R. Biphasic dissolution as an exploratory method during early drug product development [Internet]. Pharmaceutics. 2020 ; 12 1-17 art.[citado 2024 maio 20 ] Available from: https://doi.org/10.3390/pharmaceutics12050420
Vancouver
Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon GL, Löbenberg R. Biphasic dissolution as an exploratory method during early drug product development [Internet]. Pharmaceutics. 2020 ; 12 1-17 art.[citado 2024 maio 20 ] Available from: https://doi.org/10.3390/pharmaceutics12050420
Artigo de periodico
Mechanistic understanding of underperforming enteric coated products: opportunities to add clinical relevance to the dissolution test (2020)
Silva, Daniela Amaral; Davies, Neal M; Doschak, Michael R; Al-Gousous, Jozef; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar
Source: Journal of Controlled Release. Unidade: FCF
Assunto: FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. Mechanistic understanding of underperforming enteric coated products: opportunities to add clinical relevance to the dissolution test. Journal of Controlled Release, v. 325, p. 23-334, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jconrel.2020.06.031. Acesso em: 20 maio 2024.
APA
Silva, D. A., Davies, N. M., Doschak, M. R., Al-Gousous, J., Bou-Chacra, N. A., & Löbenberg, R. (2020). Mechanistic understanding of underperforming enteric coated products: opportunities to add clinical relevance to the dissolution test. Journal of Controlled Release, 325, 23-334. doi:10.1016/j.jconrel.2020.06.031
NLM
Silva DA, Davies NM, Doschak MR, Al-Gousous J, Bou-Chacra NA, Löbenberg R. Mechanistic understanding of underperforming enteric coated products: opportunities to add clinical relevance to the dissolution test [Internet]. Journal of Controlled Release. 2020 ; 325 23-334.[citado 2024 maio 20 ] Available from: https://doi.org/10.1016/j.jconrel.2020.06.031
Vancouver
Silva DA, Davies NM, Doschak MR, Al-Gousous J, Bou-Chacra NA, Löbenberg R. Mechanistic understanding of underperforming enteric coated products: opportunities to add clinical relevance to the dissolution test [Internet]. Journal of Controlled Release. 2020 ; 325 23-334.[citado 2024 maio 20 ] Available from: https://doi.org/10.1016/j.jconrel.2020.06.031
Artigo de periodico
Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: the hidden role of bicarbonate buffer (2019)
Silva, Daniela Amaral; Gousous, Jozef Al; Davies, Neal M; Bou-Chacra, Nadia Araci ; Webster, Gregory K; Lipka, Elke; Amidon, Gordon; Löbenberg, Raimar
Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: FCF
Subjects: FÁRMACOS, FORMAS FARMACÊUTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: the hidden role of bicarbonate buffer. European Journal of Pharmaceutics and Biopharmaceutics, v. 142, p. 8-19, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2019.06.006. Acesso em: 20 maio 2024.
APA
Silva, D. A., Gousous, J. A., Davies, N. M., Bou-Chacra, N. A., Webster, G. K., Lipka, E., et al. (2019). Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: the hidden role of bicarbonate buffer. European Journal of Pharmaceutics and Biopharmaceutics, 142, 8-19. doi:10.1016/j.ejpb.2019.06.006
NLM
Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon G, Löbenberg R. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: the hidden role of bicarbonate buffer [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2019 ; 142 8-19.[citado 2024 maio 20 ] Available from: https://doi.org/10.1016/j.ejpb.2019.06.006
Vancouver
Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon G, Löbenberg R. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: the hidden role of bicarbonate buffer [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2019 ; 142 8-19.[citado 2024 maio 20 ] Available from: https://doi.org/10.1016/j.ejpb.2019.06.006
Artigo de periodico
In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation (2019)
Duque, Marcelo Dutra; Silva, Daniela Amaral; Issa, Michele Georges ; Porta, Valentina ; Löbenberg, Raimar ; Ferraz, Humberto Gomes
Source: Pharmaceutics. Unidade: FCF
Subjects: BIOEQUIVALÊNCIA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUQUE, Marcelo Dutra et al. In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation. Pharmaceutics, v. 11, p. 1-12 art. 215, 2019Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics11050215. Acesso em: 20 maio 2024.
APA
Duque, M. D., Silva, D. A., Issa, M. G., Porta, V., Löbenberg, R., & Ferraz, H. G. (2019). In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation. Pharmaceutics, 11, 1-12 art. 215. doi:10.3390/pharmaceutics11050215
NLM
Duque MD, Silva DA, Issa MG, Porta V, Löbenberg R, Ferraz HG. In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation [Internet]. Pharmaceutics. 2019 ; 11 1-12 art. 215.[citado 2024 maio 20 ] Available from: https://doi.org/10.3390/pharmaceutics11050215
Vancouver
Duque MD, Silva DA, Issa MG, Porta V, Löbenberg R, Ferraz HG. In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation [Internet]. Pharmaceutics. 2019 ; 11 1-12 art. 215.[citado 2024 maio 20 ] Available from: https://doi.org/10.3390/pharmaceutics11050215
Artigo de periodico
Application of in silico tools in clinical practice using Ketoconazole as a model drug (2018)
Silva, Daniela Amaral; Duque, Marcelo Dutra; Davies, Neal M; Löbenberg, Raimar; Ferraz, Humberto Gomes
Source: Journal of Pharmacy and Pharmaceutical Sciences. Unidade: FCF
Subjects: ANTIFÚNGICOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. Application of in silico tools in clinical practice using Ketoconazole as a model drug. Journal of Pharmacy and Pharmaceutical Sciences, v. 21, n. 1s, p. 242s-253s, 2018Tradução . . Disponível em: https://www.ncbi.nlm.nih.gov/pubmed/30348250. Acesso em: 20 maio 2024.
APA
Silva, D. A., Duque, M. D., Davies, N. M., Löbenberg, R., & Ferraz, H. G. (2018). Application of in silico tools in clinical practice using Ketoconazole as a model drug. Journal of Pharmacy and Pharmaceutical Sciences, 21( 1s), 242s-253s. Recuperado de https://www.ncbi.nlm.nih.gov/pubmed/30348250
NLM
Silva DA, Duque MD, Davies NM, Löbenberg R, Ferraz HG. Application of in silico tools in clinical practice using Ketoconazole as a model drug [Internet]. Journal of Pharmacy and Pharmaceutical Sciences. 2018 ; 21( 1s): 242s-253s.[citado 2024 maio 20 ] Available from: https://www.ncbi.nlm.nih.gov/pubmed/30348250
Vancouver
Silva DA, Duque MD, Davies NM, Löbenberg R, Ferraz HG. Application of in silico tools in clinical practice using Ketoconazole as a model drug [Internet]. Journal of Pharmacy and Pharmaceutical Sciences. 2018 ; 21( 1s): 242s-253s.[citado 2024 maio 20 ] Available from: https://www.ncbi.nlm.nih.gov/pubmed/30348250
Artigo de periodico
The Significance of disintegration testing in pharmaceutical development (2018)
Silva, Daniela Amaral; Webster, Gregory K; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar
Source: Dissolution Technologies. Unidade: FCF
Subjects: FARMACOCINÉTICA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. The Significance of disintegration testing in pharmaceutical development. Dissolution Technologies, v. 25, n. 3, p. 30-38, 2018Tradução . . Disponível em: https://doi.org/10.14227/DT250318P30. Acesso em: 20 maio 2024.
APA
Silva, D. A., Webster, G. K., Bou-Chacra, N. A., & Löbenberg, R. (2018). The Significance of disintegration testing in pharmaceutical development. Dissolution Technologies, 25( 3), 30-38. doi:10.14227/DT250318P30
NLM
Silva DA, Webster GK, Bou-Chacra NA, Löbenberg R. The Significance of disintegration testing in pharmaceutical development [Internet]. Dissolution Technologies. 2018 ; 25( 3): 30-38.[citado 2024 maio 20 ] Available from: https://doi.org/10.14227/DT250318P30
Vancouver
Silva DA, Webster GK, Bou-Chacra NA, Löbenberg R. The Significance of disintegration testing in pharmaceutical development [Internet]. Dissolution Technologies. 2018 ; 25( 3): 30-38.[citado 2024 maio 20 ] Available from: https://doi.org/10.14227/DT250318P30
Artigo de periodico
In silico simulation of dissolution profiles for development of extended-release doxazosin tablets (2018)
Duque, Marcelo Dutra; Issa, Michele Georges; Silva, Daniela Amaral; Barbosa, Eduardo José; Löbenberg, Raimar; Ferraz, Humberto Gomes
Source: Dissolution Technologies. Unidade: FCF
Subjects: SOLUBILIDADE, FÁRMACOS, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUQUE, Marcelo Dutra et al. In silico simulation of dissolution profiles for development of extended-release doxazosin tablets. Dissolution Technologies, v. 25, n. 4, p. 14-21, 2018Tradução . . Disponível em: https://doi.org/10.14227/DT250418P14. Acesso em: 20 maio 2024.
APA
Duque, M. D., Issa, M. G., Silva, D. A., Barbosa, E. J., Löbenberg, R., & Ferraz, H. G. (2018). In silico simulation of dissolution profiles for development of extended-release doxazosin tablets. Dissolution Technologies, 25( 4), 14-21. doi:10.14227/DT250418P14
NLM
Duque MD, Issa MG, Silva DA, Barbosa EJ, Löbenberg R, Ferraz HG. In silico simulation of dissolution profiles for development of extended-release doxazosin tablets [Internet]. Dissolution Technologies. 2018 ; 25( 4): 14-21.[citado 2024 maio 20 ] Available from: https://doi.org/10.14227/DT250418P14
Vancouver
Duque MD, Issa MG, Silva DA, Barbosa EJ, Löbenberg R, Ferraz HG. In silico simulation of dissolution profiles for development of extended-release doxazosin tablets [Internet]. Dissolution Technologies. 2018 ; 25( 4): 14-21.[citado 2024 maio 20 ] Available from: https://doi.org/10.14227/DT250418P14
Trabalho de evento-resumo periodico
In silico simulation of dissolution profiles applied to the development of extendedrelease doxazosin tablet formulation (2017)
Duque, Marcelo Dutra; Issa, Michele Georges; Silva, Daniela Amaral; Barbosa, Eduardo José; Löbenberg, Raimar; Ferraz, Humberto Gomes
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: DESENVOLVIMENTO DE PRODUTOS, FÁRMACOS, TECNOLOGIA FARMACÊUTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUQUE, Marcelo Dutra et al. In silico simulation of dissolution profiles applied to the development of extendedrelease doxazosin tablet formulation. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 20 maio 2024. , 2017
APA
Duque, M. D., Issa, M. G., Silva, D. A., Barbosa, E. J., Löbenberg, R., & Ferraz, H. G. (2017). In silico simulation of dissolution profiles applied to the development of extendedrelease doxazosin tablet formulation. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Duque MD, Issa MG, Silva DA, Barbosa EJ, Löbenberg R, Ferraz HG. In silico simulation of dissolution profiles applied to the development of extendedrelease doxazosin tablet formulation. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 36 res. FCF067.[citado 2024 maio 20 ]
Vancouver
Duque MD, Issa MG, Silva DA, Barbosa EJ, Löbenberg R, Ferraz HG. In silico simulation of dissolution profiles applied to the development of extendedrelease doxazosin tablet formulation. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 36 res. FCF067.[citado 2024 maio 20 ]
Artigo de periodico
Intrinsic dissolution simulation of highly and poorly soluble drugs for BCS solubility classification (2017)
Duque, Marcelo Dutra; Issa, Michele Georges; Silva, Daniela Amaral; Kakuda, Beatriz Ayumi Sakamoto; Rodrigues, Leticia Norma Carpentieri; Löbenberg, Raimar; Ferraz, Humberto Gomes
Source: Dissolution Technologies. Unidade: FCF
Subjects: SOLUBILIDADE, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUQUE, Marcelo Dutra et al. Intrinsic dissolution simulation of highly and poorly soluble drugs for BCS solubility classification. Dissolution Technologies, v. 24, n. 4, p. 6-11, 2017Tradução . . Disponível em: https://doi.org/10.14227/DT240417P6. Acesso em: 20 maio 2024.
APA
Duque, M. D., Issa, M. G., Silva, D. A., Kakuda, B. A. S., Rodrigues, L. N. C., Löbenberg, R., & Ferraz, H. G. (2017). Intrinsic dissolution simulation of highly and poorly soluble drugs for BCS solubility classification. Dissolution Technologies, 24( 4), 6-11. doi:10.14227/DT240417P6
NLM
Duque MD, Issa MG, Silva DA, Kakuda BAS, Rodrigues LNC, Löbenberg R, Ferraz HG. Intrinsic dissolution simulation of highly and poorly soluble drugs for BCS solubility classification [Internet]. Dissolution Technologies. 2017 ; 24( 4): 6-11.[citado 2024 maio 20 ] Available from: https://doi.org/10.14227/DT240417P6
Vancouver
Duque MD, Issa MG, Silva DA, Kakuda BAS, Rodrigues LNC, Löbenberg R, Ferraz HG. Intrinsic dissolution simulation of highly and poorly soluble drugs for BCS solubility classification [Internet]. Dissolution Technologies. 2017 ; 24( 4): 6-11.[citado 2024 maio 20 ] Available from: https://doi.org/10.14227/DT240417P6
Trabalho de evento-resumo periodico
Intrinsic dissolution simulations using 'DDDPlus POT. TM' as a tool for early BCS classification (2016)
Duque, Marcelo Dutra; Issa, Michele Georges; Silva, Daniela Amaral; Kakuda, Beatriz Ayumi Sakamoto; Rodrigues, Leticia Norma Carpentieri; Löbenberg, Raimar; Ferraz, Humberto Gomes
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUQUE, Marcelo Dutra et al. Intrinsic dissolution simulations using 'DDDPlus POT. TM' as a tool for early BCS classification. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 20 maio 2024. , 2016
APA
Duque, M. D., Issa, M. G., Silva, D. A., Kakuda, B. A. S., Rodrigues, L. N. C., Löbenberg, R., & Ferraz, H. G. (2016). Intrinsic dissolution simulations using 'DDDPlus POT. TM' as a tool for early BCS classification. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Duque MD, Issa MG, Silva DA, Kakuda BAS, Rodrigues LNC, Löbenberg R, Ferraz HG. Intrinsic dissolution simulations using 'DDDPlus POT. TM' as a tool for early BCS classification. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 32 res. FCF060.[citado 2024 maio 20 ]
Vancouver
Duque MD, Issa MG, Silva DA, Kakuda BAS, Rodrigues LNC, Löbenberg R, Ferraz HG. Intrinsic dissolution simulations using 'DDDPlus POT. TM' as a tool for early BCS classification. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 32 res. FCF060.[citado 2024 maio 20 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Non normalized affiliation